share_log

TD Cowen Maintains Outperform on TransMedics Gr, Raises Price Target to $110

Benzinga ·  Aug 4, 2023 12:47

TD Cowen analyst Joshua Jennings maintains TransMedics Gr (NASDAQ:TMDX) with a Outperform and raises the price target from $95 to $110.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment